According to Merck's latest financial reports the company's current EPS (TTM) is $5.73. an increase over its 2021 EPS that were of $5.17.
Year | EPS | Change |
---|---|---|
2022 | $5.71 | 10.53% |
2021 | $5.17 | 84.68% |
2020 | $2.80 | -27.2% |
2019 | $3.84 | 63.44% |
2018 | $2.35 | 151.11% |
2017 | $0.94 | -54.58% |
2016 | $2.06 | 30.21% |
2015 | $1.58 | -61.99% |
2014 | $4.16 | 180.51% |
2013 | $1.48 | -31.82% |
2012 | $2.18 | 6.62% |
2011 | $2.04 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $6.83 | 19.19% | ๐บ๐ธ USA |
![]() Novartis NVS | $3.19 | -44.33% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $5.60 | -2.27% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $4.29 | -25.06% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $6.71 | 17.12% | ๐บ๐ธ USA |
![]() Amgen AMGN | $12.18 | 112.57% | ๐บ๐ธ USA |
![]() Sanofi SNY | $2.85 | -50.35% | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | $2.72 | -52.53% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $7.91 | 37.99% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | -$2.12 | -137.00% | ๐ฎ๐ฑ Israel |